Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing and treating cardiorenal syndrome and application thereof

A technology of cardiorenal syndrome and composition, applied in the direction of drug combination, pharmaceutical formula, cardiovascular system diseases, etc.

Inactive Publication Date: 2021-06-18
QIANFOSHAN HOSPITAL OF SHANDONG
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the use of benzoyl neoaconitine, benzoyl aconitine, pachylic acid A, atractylodes lactone III, and paeonifloride glycosides is used for the prevention and treatment of targeted inflammation in heart-kidney intersection diseases. Drugs, not yet reported

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating cardiorenal syndrome and application thereof
  • Pharmaceutical composition for preventing and treating cardiorenal syndrome and application thereof
  • Pharmaceutical composition for preventing and treating cardiorenal syndrome and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0045] Preparation of Capsules for Prevention and Treatment of Cardiorenal Syndrome:

[0046] Take 30g of benzoyl aconitine, 100g of benzoyl aconitine, 200g of pachylic acid A, 100g of atractylodes lactone III, 40g of paeonifloride glycoside, add appropriate amount of starch, mix well, pack into capsules, and make 1000 capsules , that is.

Embodiment 2

[0048] Preparation of dripping pills for preventing and treating cardiorenal syndrome:

[0049] Take 60 g of benzoyl neoaconitine, 50 g of benzoyl aconitine, 185 g of pachylic acid A, 140 g of atractylodes lactone III, 110 g of paeonifloride glycosides, and 500 g of polyethylene glycol, heat to melt, and mix well, Move it to the liquid reservoir of the dropping pill machine, keep it warm at 90°C, drop it into the cooled simethicone oil, and make 1000g of dropping pills.

Embodiment 3

[0051] Preparation of Injection for Prevention and Treatment of Cardiorenal Syndrome:

[0052] Take 66g of benzoyl neoaconitine, 30g of benzoyl aconitine, 170g of pachylic acid A, 140g of atractylodes lactone III, and 80g of paeonifloride glycoside, add 1800ml of water for injection, stir to dissolve, and use saturated sodium hydroxide Adjust the pH value of the solution to 7.0-7.5, add 10g of activated carbon for needles, add water for injection to 2000ml, mix well, boil for 30 minutes, refrigerate, filter, add water for injection to 5000ml, and use 0.45μm and 0.22μm microporous filters respectively Membrane filtration, sub-package, each 5ml, filled with nitrogen, sealed, steam sterilization for 30 minutes, that is, 1000 concentrated solution for injection.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a pharmaceutical composition for preventing and treating cardiorenal syndrome. The pharmaceutical composition is prepared from 2.2-8.8 parts of benzoylmesaconine, 2.5 to 10.0 parts of benzoylhypacoitine, 5.2 to 20.8 parts of pachymic acid A, 4.4 to 17.6 parts of atractylenolide III and 3.8 to 15.2 parts of albiflorin. The titer of the pharmaceutical composition for preventing and treating cardiorenal syndrome can reach 93.02%. According to the pharmaceutical composition disclosed by the invention, the contents of the benzoylmesaconine and the benzoylhypacoitine are limited, so that toxic and side effects caused by the benzoylmesaconine and the benzoylhypacoitine on a human body are avoided, the pharmaceutical composition can be used trustingly, and the curative effect is enhanced; and finally, a foundation is laid for further developing a novel active ingredient composition preparation.

Description

technical field [0001] The invention belongs to the field of research and development of traditional Chinese medicines, and in particular relates to a pharmaceutical composition for preventing and treating cardiorenal syndrome and its application. Background technique [0002] With the aging trend of society and the increasing incidence of diabetes, the coexistence of heart and kidney dysfunction is becoming more and more common. Cardiac intersection diseases have become an interdisciplinary key and difficult problem. A large number of studies have confirmed that the heart and kidney are both important organs to maintain the body's circulatory homeostasis, and the functions of the heart and kidney can affect each other. Compared with a single disease, the damage to the heart and kidney functions reflected by it is not superimposed, but exceeds the body. The sum of the morbidity and mortality of single organ failure and its resulting serious events. Modern studies have found...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/439A61K31/194A61K31/366A61K31/7048A61P9/00A61P13/12
CPCA61K31/439A61K31/194A61K31/366A61K31/7048A61P9/00A61P13/12A61K2300/00
Inventor 时海燕徐男
Owner QIANFOSHAN HOSPITAL OF SHANDONG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com